Skip to main content

Table 5 Effect of predictors and evolution of CD4 cell count on HIV infected patients on ART

From: Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam

 

Bivariate

 

Adjusted

 

Characteristics

Coeff (95% CI)

p-value

Adj.sq.Coeff (95% CI)

p-value

Intervention group

0.2 (−0.6;−0.9)

0.69

  

Female gender

−3.0 (−3.8;−2.3)

<0.001

  

Age <35 years

−0.3 (−1.1;−0.6)

0.54

  

Severe HIV (clinical stage 3 or 4)

−2.1 (−2.8;−1.4)

<0.001

  

History of IDU

−2.1 (−2.8;−1.4)

<0.001

  

ART-non-naïve status

0.8 (−0.8;2.5)

0.32

  

TB history

−0.2 (−1.2;0.8)

0.68

  

VL at baseline ≥100,000 copies/ml

−2.8 (−3.6;−2.0)

<0.001

−0.9 (−1.5;−0.3)

<0.01

CD4 at baseline <100 cells/μl

−6.8 (−7.4;−6.3)

<0.001

−5.7 (−6.3;−5.1)

<0.001

Having an HIV-infected family member

2.5 (1.8;3.3)

<0.001

1.3 (0.8;1.9)

<0.001

From Ha long CDC OPC

−0.5 (−1.2;0.3)

0.22

  

History of OIs

1.1 (0.3;1.9)

<0.01

  

Changed ART regimen

1.0 (0.1;1.8)

<0.05

  

Incomplete adherence (missing more than one doses in 24 months)

−1.3 (−3.1;0.5)

0.15

  

Month

0.4 (0.4;0.4)

<0.001

0.39 (0.38;0.41)

<0.001

  1. OIs opportunistic infections, VL viral load, IDU Injecting drug use, TB tuberculosis, ART Antiretroviral therapy, OPC outpatient clinic, Coeff Coefficient, adj.sq.Coeff adjusted square Coefficient